The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study
Abstract
BACKGROUND: We assessed the impact of infectious disease (ID) consultation on management and outcome in patients with Staphylococcus aureus bacteremia (SAB). METHODS: A retrospective cohort study examined consecutive SAB patients from 6 academic and community hospitals between 2007 and 2010. Quality measures of management including echocardiography, repeat blood culture, removal of infectious foci, and antibiotic therapy were compared between ID consultation (IDC) and no ID consultation (NIDC) groups. A competing risk model with propensity score adjustment was used to compare in-hospital mortality and time to discharge. RESULTS: Of 847 SAB patients, 506 (60%) patients received an ID consultation and 341 (40%) patients did not. Echocardiography was done for 371 (73%) IDC and 191 (56%) NIDC patients (P < .0001) in hospital. Blood cultures were repeated within 2-4 days of bacteremia in 207 (41%) IDC and 107 (31%) NIDC patients (P = .0058). The infectious foci removal rate was not statistically different between the 2 groups. For empiric therapy, 474 (94%) IDC and 297 (87%) NIDC patients received appropriate antibiotics (P = .0013). For patients who finished the planned course of antibiotics, 285 of 422 (68%) IDC and 141 of 262 (54%) NIDC patients received the appropriate duration of antibiotic therapy (P = .0004). In hospital, 204 (24%) patients died: 104 of 506 (21%) IDC and 100 of 341 (29%) NIDC patients. Matched by propensity score, ID consultation had a subdistribution hazard ratio of 0.72 (95% confidence interval [CI], .52-.99; P = .0451) for in-hospital mortality and 1.28 (95% CI, 1.06-1.56; P = .0109) for being discharged alive. CONCLUSIONS: ID consultation is associated with better adherence to quality measures, reduced in-hospital mortality, and earlier discharge in patients with SAB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Wilson, W., Taubert, K. A., Gewitz, M., Lockhart, P. B., Baddour, L. M., Levison, M., Bolger, A., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.183095 · Cited by 2,814
Friedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler, V. G., Olsen, M. K., Corey, G. R., Woods, C. W., Cabell, C. H., Reller, L. B., Cheng, A. C., Dudley, T., & Oddone, E. Z. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.17.2066 · Cited by 652
Clinical Management of Staphylococcus aureus Bacteremia: A Review
Holland, T. L., Arnold, C., & Fowler, V. G. (2014) · JAMA · doi:10.1001/jama.2014.9743 · Cited by 449
Fowler, V. G., Sanders, L. L., Sexton, D. J., Kong, L., Marr, K. A., Gopal, A. K., Gottlieb, G., McClelland, R. S., & Corey, G. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514686 · Cited by 441
Chang, F.-Y., MacDonald, B. B., Peacock, J. E., Musher, D. M., Triplett, P., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091185.93122.40 · Cited by 349
Kim, S.-H., Kim, K.-H., Kim, H.-B., Kim, N.-J., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00700-07 · Cited by 300
Laupland, K. B., Ross, T., & Gregson, D. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/589717 · Cited by 296
Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors
Harel, Z., Wald, R., Bargman, J. M., Mamdani, M., Etchells, E., Garg, A. X., Ray, J. G., Luo, J., Li, P., Quinn, R. R., et al. (2013) · Kidney International · doi:10.1038/ki.2012.451 · Cited by 288
Self-citationSharma, G., Kuo, Y.-F., Freeman, J. L., Zhang, D. D., & Goodwin, J. S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.345 · Cited by 259
Schweizer, M. L., Furuno, J. P., Harris, A. D., Johnson, J. K., Shardell, M. D., McGregor, J. C., Thom, K. A., Cosgrove, S. E., Sakoulas, G., & Perencevich, E. N. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-279 · Cited by 254
Jenkins, T. C., Price, C. S., Sabel, A. L., Mehler, P. S., & Burman, W. J. (2008) · Clinical Infectious Diseases · doi:10.1086/529190 · Cited by 216
Wyllie, D. H., Crook, D. W., & Peto, T. E. A. (2006) · BMJ · doi:10.1136/bmj.38834.421713.2f · Cited by 210
Ayanian, J. Z., Landrum, M. B., Guadagnoli, E., & Gaccione, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa020080 · Cited by 205
Staphylococcus aureus Bacteremia: Predictors of 30-Day Mortality in a Large Cohort
Mylotte, J. M., & Tayara, A. (2000) · Clinical Infectious Diseases · doi:10.1086/317421 · Cited by 190
The Value of Infectious Diseases Consultation in Staphylococcus aureus Bacteremia
Honda, H., Krauss, M. J., Jones, J. C., Olsen, M. A., & Warren, D. K. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.01.015 · Cited by 189
Rieg, S., Peyerl-Hoffmann, G., de With, K., Theilacker, C., Wagner, D., Hübner, J., Dettenkofer, M., Kaasch, A., Seifert, H., Schneider, C., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.07.015 · Cited by 181
Impact of specialist follow-up in outpatients with congestive heart failure
Ezekowitz, J. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1032017 · Cited by 177
Kaech, C., Elzi, L., Sendi, P., Frei, R., Laifer, G., Bassetti, S., & Flückiger, U. M. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01359.x · Cited by 174
Infectious Diseases Consultation Lowers Mortality From Staphylococcus aureus Bacteremia
Lahey, T., Shah, R., Gittzus, J., Schwartzman, J. D., & Kirkland, K. B. (2009) · Medicine · doi:10.1097/md.0b013e3181b8fccb · Cited by 143
How to handle mortality when investigating length of hospital stay and time to clinical stability
Brock, G. N., Barnes, C., Ramirez, J. A., & Myers, J. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-144 · Cited by 138
McClelland, R. S., Fowler, V. G., Sanders, L. L., Gottlieb, G. S., Kong, L., Sexton, D. J., Schmader, K. E., Lanclos, K., & Corey, G. R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1244 · Cited by 136
Forsblom, E., Ruotsalainen, E., Ollgren, J. P., & Järvinen, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis889 · Cited by 135
Chong, Y. P., Moon, S. M., Bang, K. M., Park, H. J., Park, S.-Y., Kim, M., Park, K., Kim, S., Lee, S., Choi, S., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01021-12 · Cited by 124
Robinson, J. O., Langhi, S., Phillips, M. R., Pearson, J. C., Christiansen, K., Coombs, G. W., & Murray, R. J. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1585-y · Cited by 106
Predicting Risk for Death from MRSA Bacteremia1
Pastagia, M., Kleinman, L. C., Lacerda, E., & Jenkins, S. G. (2012) · Emerging infectious diseases · doi:10.3201/eid1807.101371 · Cited by 98
Ruotsalainen, E., Sammalkorpi, K., Laine, J., Huotari, K., Sarna, S. J., Valtonen, V., & Järvinen, A. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-137 · Cited by 88
Nagao, M., Iinuma, Y., SAITO, T. K., Matsumura, Y., Shirano, M., Matsushima, A., Takakura, S., Ito, Y., & Ichiyama, S. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03156.x · Cited by 86
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality
Tissot, F., Calandra, T., Prod’hom, G., Taffé, P., Zanetti, G. M. R., Greub, G., & Senn, L. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.05.004 · Cited by 75
Pragman, A. A., Kuskowski, M. A., Abraham, J. M., & FILICE, G. A. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318255d67c · Cited by 51
Infectious Diseases Consultation and the Management of Staphylococcus aureus Bacteremia
Fries, B., Licitra, C. M., Crespo, A., Akhter, K., Busowski, M. T., Salazar, D., & Wallace, M. R. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit730 · Cited by 46
Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan
Isobe, M., Seki, M., Yamagishi, Y., Miyawaki, K., Yabuno, K., Hamaguchi, S., Yoshioka, N., Tomono, K., Isobe, M., Uejima, E., et al. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0423-6 · Cited by 35
Choi, S.-H., Cho, S. Y., Park, J., & Chung, J.-W. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.12.002 · Cited by 30
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“Superior empiric coverage can be obtained using local and unit-specific antibiograms [113, 114] or an infectious diseases consultation [115-117].”
BackgroundSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Practical recommendations for reportingFine‐Gray model analyses for competing risk data
Austin, P. C., & Fine, J. P. (2017) · Statistics in Medicine · doi:10.1002/sim.7501 · Cited by 1,271
Schuts, E. C., Hulscher, M. E. J. L., Mouton, J. W., Verduin, C. M., Stuart, J. W. T. C., Overdiek, H. W. P. M., van der Linden, P. D., Natsch, S., Hertogh, C. M. P. M., Wolfs, T. F. W., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00065-7 · Cited by 758
Metadata
- Authors
- Bai, A. D., Showler, A., Burry, L., Steinberg, M., Ricciuto, D. R., Fernandes, T., Chiu, A., Raybardhan, S., Science, M., Fernando, E., Tomlinson, G., Bell, C. M., & Morris, A. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-02-20
- Volume
- 60
- Issue
- 10
- Pages
- 1451-1461
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2108661760
- Cited by
- 254
- References
- 41
- FWCI
- 18.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.